Divis Laboratories informs about disclosure

15 Mar 2019

Divis Laboratories has informed that exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Reliance Nippon Life Asset Management.

The above information is a part of company’s filings submitted to BSE.

Related Divis Laboratories Ltd. Links:

Divis Lab Share Price

3047.40 -9.90 (-0.32%) Sep 30, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 500.50
Dr. Reddys Lab 5187.05
Lupin 1007.10
Piramal Enterprises 1251.95
Cadila Healthcare 394.90
View more..
Sensex vs Divis Lab
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback